Skip to main content

Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation (AF) at Discharge

CBE ID
0241
1.4 Project
Neurology
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2015
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) with documented permanent, persistent, or paroxysmal atrial fibrillation who were prescribed an anticoagulant at discharge

    • 1.14 Numerator

      Patients who were prescribed an anticoagulant at discharge

    • 1.15 Denominator

      All patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) with documented permanent, persistent, or paroxysmal atrial fibrillation

    • Exclusions

      All patients that expired during inpatient stay are excluded.

      Documentation of medical reason(s) for not prescribing anticoagulant therapy at discharge (eg, other medical reason(s))

      Documentation of patient reason(s) for not prescribing anticoagulant therapy at discharge (eg, patient is receiving comfort care only, patient left against medical advice, other patient reason(s))

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Neurology Project 2015-2016
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American Academy of Neurology
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) convened Physician Consortium for Performance Improvement® (PCPI™) and the National Committee for Quality Assurance (NCQA).
      These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.
      The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, NCQA, PCPI nor its members shall be responsible for any use of the Measures.
      THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND

      © 2012 American Medical Association and the National Committee for Quality Assurance. All Rights Reserved.
      Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.
      CPT® contained in the Measure specifications is copyright 2004- 2011 American Medical Association.
      LOINC® copyright 2004--2011 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms® (SNOMED CT®) copyright 2004-2011 International Health Terminology Standards Development Organisation. ICD-10 Copyright 2011 World Health Organization. All Rights Reserved.